The Trump administration has imposed a nationwide six-month freeze on new Medicare enrollments for hospice and home health agencies, a move that will temporarily halt new providers from signing up for reimbursement from the federal insurance program for older adults. This action comes as people across the United States face rising health costs and increasing barriers to access, some directly resulting from federal government policies.
The Centers for Medicare and Medicaid Services (CMS) announced the moratorium, stating its purpose is to combat “systemic and deeply troubling fraud” within the hospice and home health sectors. CMS Administrator Dr. Mehmet Oz claimed the freeze would “shut the door on fraud,” preventing “new bad actors from entering Medicare” while existing ones are aggressively identified, investigated, and removed. This narrative frames the state's intervention as a protective measure against individual malfeasance rather than addressing the structural conditions that incentivize such actions within a profit-driven healthcare system.
The State's Hand in Healthcare
This initiative is linked to Vice President JD Vance’s anti-fraud task force, established by Republican President Donald Trump to address alleged misuse of public funds. The administration contends that this freeze and other actions will help prevent potential fraud in Medicaid and Medicare, thereby preserving funding and resources for people most in need. However, the state's own policies simultaneously create significant barriers to care. New work requirements imposed in Medicaid, for example, are expected to strain hospitals around the country and result in millions of enrollees losing their health coverage. This demonstrates a contradictory approach where the state claims to protect public funds while actively reducing access to essential services for the working class and economically dispossessed.
While states acknowledge legitimate concerns about fraud in hospice and home health care, some have pushed back on the administration’s aggressive tactics. Critics have warned that these “catchall efforts” could “needlessly punish law-abiding providers” that are attempting to serve patients, further exacerbating the existing challenges in healthcare access. Under the six-month pause, existing hospice and home health care providers will continue operations as usual, but CMS stated it would “intensify targeted investigations, deploy advanced data analytics, and accelerate the removal” of providers suspected of fraudulent activity.
Who Bears the Cost of Systemic Failure
The freeze on new enrollments directly impacts the expansion of care options, particularly in areas where new providers might be needed most. This restriction on new entrants into the Medicare reimbursement system, even if temporary, limits the availability of services for vulnerable Medicare patients. The focus on “fraud-busting” diverts attention from the broader crisis of healthcare affordability and access, which is a direct consequence of a system designed to concentrate wealth upward through private enterprise. The cost of this systemic failure is borne by patients who face rising costs and reduced access, and by providers navigating an increasingly punitive regulatory environment.
Such moratoria are not unprecedented, revealing a consistent, bipartisan strategy by the state to manage the contradictions of a privatized healthcare system. Tricia Neumann, a senior vice president and executive director for the program on Medicare policy at the health care research nonprofit KFF, noted that President Bill Clinton’s Democratic administration also imposed a temporary moratorium on home health agencies. Neumann suggested a “brief moratorium gives the administration time to crack down on true fraud and prevent new fraudulent entities from popping up.” This historical precedent illustrates how both liberal and conservative administrations employ similar tactics to address symptoms of a profit-driven system without challenging its fundamental structure.
Managing Contradictions, Not Curing Ailments
In recent months, CMS has already suspended payments to hundreds of hospice and home care agencies in Los Angeles over alleged fraud. The administration also issued another six-month moratorium on suppliers of durable medical equipment, prosthetics, orthotics, and certain other supplies in Medicare. Further extending its reach, the administration has approached at least five states with investigations into potential health care fraud and halted approximately $243 million in Medicaid payments to Minnesota over such concerns. Last month, CMS Administrator Oz announced a new requirement for all 50 states to share how they planned to revalidate some of their Medicaid providers, expanding state oversight across the country.
Despite these aggressive and widespread enforcement actions, the administration has demonstrated flaws in its own investigative methods. In April, CMS admitted to The Associated Press that it made a significant error in figures it used to help justify a fraud probe in New York. This acknowledgment deepened doubts in the administration’s methods and reinforced a common criticism that has been made about the second Trump administration — that it tends to “attack first and confirm the facts later.” This pattern reveals the state's primary function as an enforcer of capital's interests, even when its methods are flawed, rather than a neutral arbiter ensuring universal access to healthcare. The ongoing crisis of healthcare access and cost remains unaddressed by these measures, which merely manage the symptoms of a system built on surplus extraction.